ParaPRO: Innovations in Life Sciences

ParaPRO News


October 17, 2011
Multi-center Clinical Trial Shows ParaPRO’s Spinosad Eradicates Head Lice and Nits
Read the full press release

August 15, 2011
Newest Head Lice Treatment Now Available to Meet Strong Demand
Read the full press release

May 10, 2011
ParaPRO Announces Medicaid Therapeutic Committee Recommendation in Indiana for Natroba™
Read the full press release


July 26, 2010
The American Academy of Pediatrics released their Updated Head Lice Report in the online version of Pediatrics earlier this week. Key points include a call to abandon school No Nit Policies , pediatricians are encouraged to take an active role in diagnosis and providing information, diagnosis needs to be confirmed before treatment and treatments should have a clinical record of efficacy and safety for consideration.
Read the full story





Ask your doctor if Natroba™ Topical Suspension is right for you or your child.

Natroba™ Topical Suspension is a pediculicide indicated for the topical treatment of head lice infestations in patients six (6) months of age and older.

Natroba™ Topical Suspension should be used in the context of an overall lice management program:
  • Wash (in hot water) or dry clean all recently worn clothing, hats, used bedding and towels
  • Wash personal care items such as combs, brushes, and hair clips in hot water
A fine-toothed comb or special nit comb may be used to remove dead lice and nits.

Natroba™ Topical Suspension contains benzyl alcohol and is not recommended for use in neonates and infants below the age of 6 months. Systemic exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants. Most common adverse events were: application site redness (3%), eye redness (2%) and application site irritation (1%).

Consult the Patient Information, Full Prescribing Information and your doctor for more complete information on Natroba™ Topical Suspension.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.